IAPP

IAPP

Target · Peptide hormone

IAPP Islet amyloid polypeptide · Amylin

IAPP (islet amyloid polypeptide, also known as amylin, DAP and IAP) is a glucoregulatory peptide hormone of the calcitonin family. It is released from pancreatic beta cells after food intake and contributes to the regulation of energy homeostasis. Browse Assay Genie's current range of IAPP research reagents below, or read on for the biology behind the target.

Secreted peptide hormoneCalcitonin family memberSatiation signal
89 aa
Protein length
~10 kDa
Molecular weight
12p12.1
Gene locus
Calcitonin family
Protein family
Target information

What is IAPP (islet amyloid polypeptide)?

IAPP is a glucoregulatory peptide hormone that plays an important role in the regulation of energy homeostasis. It selectively inhibits insulin-stimulated glucose utilisation and glycogen deposition in muscle, without affecting glucose metabolism in adipocytes. After food intake the hormone is released from pancreatic beta cells, where it helps regulate blood glucose levels and acts as a satiation signal.

IAPP signals through the CALCR-RAMP receptor complexes, known as AMYRs. Amylin can also bind the CALCR receptor in the absence of RAMPs, although it is more selective for AMYRs. The protein is secreted and belongs to the calcitonin family of peptide hormones; HGNC places the IAPP gene in the neuropeptides gene group. Orthologous genes are named Iapp in both mouse and rat.

The name islet amyloid polypeptide sits alongside the alternative names amylin, DAP and IAP. In disease research, patients with type 1 and advanced type 2 diabetes show reduced levels of the hormone in blood and pancreas. The protein also exhibits bactericidal, antimicrobial activity, which adds a further dimension to its biology beyond metabolic control. Researchers studying the IAPP protein therefore work across diabetes, appetite regulation and peptide-receptor pharmacology.

Diabetes research

Levels of IAPP are reduced in the blood and pancreas of patients with type 1 and advanced type 2 diabetes.

Glucose homeostasis

IAPP is released from pancreatic beta cells after feeding and helps regulate blood glucose levels.

Appetite and satiety

Amylin acts as a satiation signal and contributes to the regulation of energy homeostasis.

Receptor signalling studies

IAPP acts through CALCR-RAMP complexes (AMYRs) and can also bind CALCR without RAMPs.

Background

IAPP frequently asked questions

What does IAPP do?

IAPP is a glucoregulatory peptide hormone involved in energy homeostasis. It selectively inhibits insulin-stimulated glucose utilisation and glycogen deposition in muscle, and it is released from pancreatic beta cells after food intake to regulate blood glucose and signal satiation.

What other names is IAPP known by?

IAPP stands for islet amyloid polypeptide and is also called amylin. Other aliases listed are DAP and IAP. Its receptors are the CALCR-RAMP complexes, termed AMYRs, and it belongs to the calcitonin family of peptide hormones.

Is IAPP linked to disease or conserved in other species?

Patients with type 1 and advanced type 2 diabetes have reduced IAPP in blood and pancreas. The protein also shows antimicrobial activity. Mouse and rat carry orthologous Iapp genes; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Calcitonin family members, amylin receptor components and glucose-regulation partners with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P10997; product specifications from Assay Genie datasheets.

IAPP Product listing